Angiogenesis biomarkers in prostate cancer: Unlocking new avenues for prognosis and diagnosis

This publication has 22 references indexed in Scilit:

• Osteopontin and breast cancer metastasis: Possible role of genistein on the regulation of osteopontin
  Phytomedicine Plus, 2021
• Cancer statistics for the year 2020: An overview
  International Journal of Cancer, 2021
• The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy
  European Urology, 2021
• Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
  European Urology, 2018
• Prostate-Specific Antigen (PSA) Screening for Prostate Cancer
  JAMA, 2018
• Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status
  The Prostate, 2009
• Osteopontin: role in cell signaling and cancer progression
  Trends in Cell Biology, 2006
• Angiogenesis and the tumour hypoxia response in prostate cancer: A review
  International Journal of Surgery, 2005
• Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
  Cancer Cell, 2003
• Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
  Cell, 1997